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Introduction {#sec006}
============

The gut microbiota is one of the most complex systems in human body, which comprises about 10^14^ microbes, outnumbering human cells by 10-fold \[[@pone.0161174.ref001]--[@pone.0161174.ref003]\]. The majority of microbes have an extensive influence on human, including digestion, immunity, energy homeostasis, vitamin synthesis, etc. \[[@pone.0161174.ref004]--[@pone.0161174.ref007]\]. Alteration of the gut microbiota has been associated with both digestive and extra-digestive disorders \[[@pone.0161174.ref008]--[@pone.0161174.ref012]\]. Novel strategy for treatment of bacteria-associated diseases, via modulating the gut microbiota, is underway to establish its pivotal role.

Fecal microbiota transplantation (FMT), also known as fecal bacteriotherapy or intestinal microbiota transplantation, is defined as the perfusion of treated feces from a healthy donor via the upper or lower gastrointestinal route \[[@pone.0161174.ref013]\]. About 1700 years ago, Ge Hong, a well-known traditional Chinese medicine doctor, firstly described the use of human fecal suspension by mouth for patients with food poisoning or severe diarrhea \[[@pone.0161174.ref014]\]. In 1958, Eiseman *et al* applied FMT to treat antibiotic-associated diarrhea \[[@pone.0161174.ref015]\]. Since Schwan *et al* reported the first FMT therapy for CDI in 1983 \[[@pone.0161174.ref016]\], the application of FMT in CDI has been practiced extensively \[[@pone.0161174.ref017]--[@pone.0161174.ref019]\]. The effective rate of FMT for recurrent or refractory CDI was over 90% \[[@pone.0161174.ref020], [@pone.0161174.ref021]\]. Although FMT is still regarded as an investigational agent and requires an investigational new drug (IND) application, the US FDA has already recommended FMT as an alternative therapy for recurrence of CDI after a pulsed vancomycin regimen \[[@pone.0161174.ref022]\]. Moreover, FMT shows remarkable therapeutic potential in diverse conditions \[[@pone.0161174.ref013], [@pone.0161174.ref023]\] including inflammatory bowel diseases (IBD) \[[@pone.0161174.ref024], [@pone.0161174.ref025]\], irritable bowel syndrome (IBS) \[[@pone.0161174.ref026]--[@pone.0161174.ref028]\], metabolic diseases \[[@pone.0161174.ref004], [@pone.0161174.ref029], [@pone.0161174.ref030]\], neuropsychiatric conditions \[[@pone.0161174.ref031]\], autoimmune diseases \[[@pone.0161174.ref032], [@pone.0161174.ref033]\], allergic disorders \[[@pone.0161174.ref034], [@pone.0161174.ref035]\], and chronic fatigue syndrome \[[@pone.0161174.ref036]\].

Although patients benefit from FMT, concerns about this emerging strategy remain to be addressed, including long-term outcomes of FMT and the AEs. So far, the exact roles of the gut microbiota in FMT are not yet fully understood. And the AEs that happen during or after FMT still perplex clinicians and fundamental researchers. Hence, we systematically reviewed the AEs of FMT in all related publications aiming to elucidate the causality between FMT and the AEs. Furthermore, the AEs of FMT were divided into different degrees according to the severity and SAEs were emphatically introduced to arouse attention in FMT.

Methods {#sec007}
=======

Information Sources and Search Strategy {#sec008}
---------------------------------------

Electronic databases for literature search included the Medline, Embase, and Cochrane Library. The last search was run on July 2015. The complete string used for the electronic search is shown in [Table 1](#pone.0161174.t001){ref-type="table"}. All the deriving terms were combined by the Boolean operator "OR" to assure the identification of studies regarding FMT.

10.1371/journal.pone.0161174.t001

###### Complete String Used for the Electronic Search.

![](pone.0161174.t001){#pone.0161174.t001g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  (fecal microbiota transplantation) OR (fecal transplantation) OR (feces transplantation) OR (stool transplantation) OR (microflora transplantation) OR (fecal flora transplantation) OR (fecal transplant) OR (fecal microbiota transplant) OR (feces transplant) OR (stool transplant) OR (microflora transplant) OR (fecal flora transplant) OR (fecal bacteriotherapy) OR (fecal microbiota bacteriotherapy) OR (feces bacteriotherapy) OR (stool bacteriotherapy) OR (microflora bacteriotherapy) OR (fecal flora bacteriotherapy) OR (fecal suspension) OR (fecal microbiota suspension) OR (feces suspension) OR (stool suspension) OR (microflora suspension) OR (fecal flora suspension) OR (fecal donation) OR (fecal microbiota donation) OR (feces donation) OR (stool donation) OR (microflora donation) OR (fecal flora donation) OR (fecal donor) OR (fecal microbiota donor) OR (feces donor) OR (stool donor) OR (microflora donor) OR (fecal flora donor) OR (fecal transfer) OR (fecal microbiota transfer) OR (feces transfer) OR (stool transfer) OR (microflora transfer) OR (fecal flora transfer) OR (fecal infusion) OR (fecal microbiota infusion) OR (feces infusion) OR (stool infusion) OR (microflora infusion) OR (fecal flora infusion) OR (fecal implantation) OR (fecal microbiota implantation) OR (feces implantation) OR (stool implantation) OR (microflora implantation) OR (fecal flora implantation) OR (fecal implant) OR (fecal microbiota implant) OR (feces implant) OR (stool implant) OR (microflora implant) OR (fecal flora implant) OR (fecal instillation) OR (fecal microbiota instillation) OR (feces instillation) OR (stool instillation) OR (microflora instillation) OR (fecal flora instillation) OR (fecal microbiota reconstitution) OR (fecal reconstitution) OR (feces reconstitution) OR (stool reconstitution) OR (microflora reconstitution) OR (fecal flora reconstitution)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Study selection {#sec009}
---------------

Titles, abstracts, and keywords were independently assessed by two investigators (WSN and XMQ) to determine the appropriateness of the publications. Both investigators checked all the articles in accordance with the inclusion criteria and exclusion criteria. Disagreement was resolved by a third investigator (CHL). Original full-text articles, letters to the editor, abstracts of scientific conferences, case reports and case series which were published between 1913 and 2015 were reviewed. Studies involving the AEs of FMT for human sujects of any age were included into this study. Studies evaluating treatments with cultured bacteria other than human feces, animal studies and non-original reports (reviews, systematic reviews, meta-analyses, editorials, etc) were excluded.

Data Collection and List of Items {#sec010}
---------------------------------

Data extraction was conducted according to the above mentioned inclusion and exclusion criteria and cross-checked by the two independent investigators (WSN and XMQ). When publications included patients from a previous study and newly enrolled ones, only the latter were brought into the study. Items of this study were listed as follows: (i) the study characteristics (the first author, the year of publication, the length of follow-up); (ii) the patients (the number, the reason for FMT, the prior therapy); (iii) the relationship between donors and recipients; (iv) the FMT procedure (the patient preparation for FMT, the weight of infused stools, the route of infusion, the number of infusion); (v) the detailed descriptions of AEs (the onset time, the causality between AEs and FMT, how the AEs relieve and the outcomes).

Definition of causality between the AEs and FMT {#sec011}
-----------------------------------------------

The relationship between the AEs and FMT were categorized into four types as previously dsecribed with minor modifications: definitely related, probably related, possibly related, and unrelated to FMT \[[@pone.0161174.ref037]\].

### Definitely related {#sec012}

AEs caused by endoscopic procedure during FMT; an event that follows a reasonable temporal sequence from FMT exposure; that follows a known or expected response pattern to the FMT; that is confirmed by stopping the FMT procedure; and that is not explained by any other reasonable hypothesis.

### Probably related {#sec013}

An event that follows a reasonable temporal sequence from FMT procedure; that follows a known or expected response pattern to the FMT; that is confirmed by stopping the FMT procedure; and that is unlikely to be explained by the known characteristics of the subject's clinical state or by other interventions.

### Possibly related {#sec014}

An event that follows a reasonable temporal sequence from FMT procedure; that follows a known or expected response pattern to FMT; but that could readily have been caused by a number of other factors.

### Unrelated {#sec015}

An event that can be determined with certainty to have no relationship to FMT.

Definition of severity of AEs {#sec016}
-----------------------------

### Adverse events (AEs) {#sec017}

AE is defined as any untoward medical occurrence in a patient after administration of FMT that does not necessarily have a causal relationship with this treatment. Therefore, an AE can be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with FMT, whether or not related to the FMT \[[@pone.0161174.ref037]\].

### Serious adverse events (SAEs) {#sec018}

A SAE is any adverse experience occurring during or after FMT that results in any of the following outcomes: death, life-threatening experience, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, congenital anomaly or birth defect, or an important medical event \[[@pone.0161174.ref037]\].

Results {#sec019}
=======

Included studies {#sec020}
----------------

A total of 7562 original articles about FMT were identified. Among them, 534 were selected for further assessment according to the titles. After reviewing the full text articles, 50 of them fulfilled the inclusion criteria among which 16 were case series, 9 were case reports and 4 were randomized controlled trials ([Fig 1](#pone.0161174.g001){ref-type="fig"}). The excluded articles were presented in [S1 Appendix](#pone.0161174.s001){ref-type="supplementary-material"}. Besides, conference abstracts and letters to the editor were included. The included studies were published during the period from 1998 to 2015, with a span of 18 years. The follow-up time after FMT ranged between 2 weeks to 68 months.

![Flow chart of studies of adverse events of fecal microbiota transplantation.\
FMT: fecal microbiota transplantation, CDI: *Clostridium difficile* infection, IBD: inflammatory bowel disease, IBS: irritable bowel syndrome.](pone.0161174.g001){#pone.0161174.g001}

Patient characteristics {#sec021}
-----------------------

In the selected 50 publications, a total of 1089 patients were treated with FMT (age range: 1--95 years). Among them, 831 patients were affected by refractory or recurrent CDI, of whom 106 had concomitant IBD; 235 were affected by independent IBD; 1 affected by early onset colitis; 9 affected by antibiotic-associated diarrhea (AAD), of whom 6 had concomitant CDI; and 13 affected by IBS. Overall, 78 kinds of AEs were reported to happen on 310 patients during or after FMT. The majority of AEs were presented as mild symptoms such as abdominal disomfort, diarrhea, transient fever, nausea, vomiting and constipation. Each AE was cited once for one patient since the AE always recorded only once during a multiple FMT in one course of treatment.

Since AEs usually overlapped, we could not obtain the exact total number of patients with AEs in a publication. Hence, we took the number of patients with the most frequent kind of AEs from each publication for further calculating the overall incidence of AEs. Based on the above mentioned statistical principles, the overall incidence of AEs was 28.5% (310/1089). The incidences of AEs in CDI and non-CDI (IBD, AAD, IBS and early onset colitis) were 28.0% (233/831) and 29.8% (77/258) respectively.

Causality between AEs and FMT {#sec022}
-----------------------------

Many factors could be involved in the development of AEs, including the individual difference of recipients, donors, methods of administration and regimen of FMT. The causality between AEs (including SAEs) and FMT was analyzed according to the description as above \[[@pone.0161174.ref037]\]. As a result, AEs were described to be attributable to FMT in 42 publications (Tables [2](#pone.0161174.t002){ref-type="table"} and [3](#pone.0161174.t003){ref-type="table"}). Five kinds of AEs were reported to be definitely related to FMT in 5 publications. Thirty-eight kinds of AEs, probably related to FMT, were reported in 35 articles and were considered as results of temporary systemic immune response to the applied bacteria. In addition, 25 kinds of AEs were reported to be possibly related to FMT in 13 articles. Finally, 38 kinds of AEs were reported to be unrelated to FMT in 22 articles ([Table 4](#pone.0161174.t004){ref-type="table"}).

10.1371/journal.pone.0161174.t002

###### Attributable adverse events are grouped by route of administration (Upper gastrointestinal routes; Lower gastrointestinal routes).
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  First Author, Year (Ref.)                           AEs                                                                                                                                                                                                                                          The number of patients with AEs   Sample size   Causality between AEs and FMT   Routes of infusion
  --------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------- ------------- ------------------------------- -----------------------------------------------
  **Upper gastrointestinal routes**                                                                                                                                                                                                                                                                                                                                                
  **Vermeire, 2012 \[[@pone.0161174.ref060]\]**       Fever; Abdominal tenderness                                                                                                                                                                                                                  3                                 4             Probably                        Nasojejunal tube
  **Cui, 2014 \[[@pone.0161174.ref041]\]**            Fever; Increased diarrhea                                                                                                                                                                                                                    7                                 30            Probably                        Gastroscopy (mid-gut)
  **Van Nood, 2013 \[[@pone.0161174.ref061]\]**       Belching; Nausea; Abdominal cramps; Diarrhea; Abdominal pain; Infection; Dizziness combined with diarrhea; Constipation                                                                                                                      27                                29            Probably                        Nasoduodenal tube
  **Aas, 2003 \[[@pone.0161174.ref062]\]**            Death from peritonitis                                                                                                                                                                                                                       1                                 18            Possibly                        Nasogastric tube
  **MacConnachie, 2009 \[[@pone.0161174.ref042]\]**   Upper gastrointestinal hemorrhage                                                                                                                                                                                                            1                                 15            Possibly                        Nasogastric tube
  **Kronman, 2015 \[[@pone.0161174.ref063]\]**        Vomiting; Mucoid stools                                                                                                                                                                                                                      1                                 10            Probably                        Nasogastric, nasoduodenal or nasojejunal tube
  **Pinn, 2014 \[[@pone.0161174.ref026]\]**           Flatulence                                                                                                                                                                                                                                   1                                 13            Probably                        Esophagogastroduodenoscopy
  **Wang, 2013 \[[@pone.0161174.ref064]\]**           Diarrhea                                                                                                                                                                                                                                     5                                 16            Probably                        Gastroscopy
  **Suskind, 2015 \[[@pone.0161174.ref065]\]**        Rhinorrhea; Sore throat                                                                                                                                                                                                                      5                                 9             Definitely                      Nasogastric tube
  Abdominal pain; Bloating; Diarrhea; Flatulence      Probably                                                                                                                                                                                                                                                                                                                     
  **Suskind, 2015 \[[@pone.0161174.ref066]\]**        Nasal stuffiness; Flatulence                                                                                                                                                                                                                 1                                 4             Probably                        Nasogastric tube
  Bloating                                            Possibly                                                                                                                                                                                                                                                                                                                     
  **Rossen, 2015 \[[@pone.0161174.ref050]\]**         Discomfort tube placement; Fever; Nausea; Malaise; Increase of stool frequency/diarrhea; Headache; Vomited fecal infusion; Vomited bowel prep; Vomiting; Abdominal cramps; Abdominal pain; Abdominal murmurs; Dizziness; Mild constipation   34                                48            Probably                        Nasoduodenal tube
  **Borody, 2003 \[[@pone.0161174.ref067]\]**         Sore throat                                                                                                                                                                                                                                  3                                 8             Definitely                      Nasojejunal tube
  **Lower gastrointestinal routes**                                                                                                                                                                                                                                                                                                                                                
  **Kump, 2013 \[[@pone.0161174.ref068]\]**           Fever; Temporary increase of CRP and IL-6; Increase in stool frequency                                                                                                                                                                       1                                 6             Probably                        Colonoscopy
  **Zhang, 2013 \[[@pone.0161174.ref069]\]**          Severe cold                                                                                                                                                                                                                                  1                                 1             Possibly                        Colonoscopy
  **Quera, 2013 \[[@pone.0161174.ref044]\]**          Fever; Bacteremia                                                                                                                                                                                                                            1                                 1             Probably                        Colonoscopy
  **Kunde, 2013 \[[@pone.0161174.ref070]\]**          Fever; Chills; Abdominal fullness                                                                                                                                                                                                            2                                 10            Probably                        Enema
  UC flare                                            Possibly                                                                                                                                                                                                                                                                                                                     
  **Gustafsson, 1998 \[[@pone.0161174.ref071]\]**     Diarrhea                                                                                                                                                                                                                                     3                                 9             Probably                        Enema
  **Lee, 2014 \[[@pone.0161174.ref072]\]**            Transient constipation; Excess flatulence                                                                                                                                                                                                    9                                 94            Probably                        Enema
  **Hamilton, 2012 \[[@pone.0161174.ref073]\]**       Irregularity of bowel movements; Excessive flatulence                                                                                                                                                                                        14                                43            Probably                        Colonoscopy
  **Khoruts, 2010 \[[@pone.0161174.ref074]\]**        Constipation; Irregularity of bowel movements                                                                                                                                                                                                1                                 1             Probably                        Colonoscopy
  **Pierog, 2014 \[[@pone.0161174.ref075]\]**         Appendicitis                                                                                                                                                                                                                                 1                                 6             Possibly                        Colonoscopy
  **Silverman, 2010 \[[@pone.0161174.ref076]\]**      Urinary tract infections                                                                                                                                                                                                                     2                                 7             Possibly                        Enema
  **Hohmann, 2014 \[[@pone.0161174.ref039]\]**        Cytomegalovirus colitis                                                                                                                                                                                                                      1                                 1             Probably                        Enema
  **De Leon, 2013 \[[@pone.0161174.ref040]\]**        Transient relapse of UC                                                                                                                                                                                                                      1                                 1             Probably                        Colonoscopy
  **Schwartz, 2013 \[[@pone.0161174.ref043]\]**       Norovirus Gastroenteritis                                                                                                                                                                                                                    1                                 13            Probably                        Colonoscopy
  **Brandt, 2012 \[[@pone.0161174.ref020]\]**         Peripheral neuropathy; Sjogren's disease; Idiopathic Thrombocytopenic purpura; Rheumatoid arthritis                                                                                                                                          4                                 77            Possibly                        Colonoscopy
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**         Relapse of CDI                                                                                                                                                                                                                               1                                 13            Possibly                        Colonoscopy
  **Mandalia, 2014\[[@pone.0161174.ref078]\]**        Diverticulitis; Fever                                                                                                                                                                                                                        1                                 1             Probably                        Colonoscopy
  **Dutta, 2014 \[[@pone.0161174.ref079]\]**          Fever; Bloating                                                                                                                                                                                                                              5                                 27            Probably                        Enteroscopy and colonoscopy
  **Ray, 2014 \[[@pone.0161174.ref080]\]**            Pain/nausea; Bloating/cramps; Gas/nausea                                                                                                                                                                                                     4                                 20            Probably                        Colonoscopy
  Continuing diarrhea                                 Possibly                                                                                                                                                                                                                                                                                                                     
  **Satokari, 2015 \[[@pone.0161174.ref053]\]**       Mild transient fever                                                                                                                                                                                                                         2                                 49            Probably                        Colonoscopy
  **Sun, 2014 \[[@pone.0161174.ref045]\]**            Multi-organism bacteremia                                                                                                                                                                                                                    1                                 1             Probably                        Colonoscopy
  **Mandalia, 2014 \[[@pone.0161174.ref081]\]**       Abdominal pain                                                                                                                                                                                                                               1                                 29            Probably                        Colonoscopy
  **Cammarota, 2015 \[[@pone.0161174.ref049]\]**      Diarrhea; Bloating and abdominal cramping                                                                                                                                                                                                    19                                20            Probably                        Colonoscopy

10.1371/journal.pone.0161174.t003

###### Attributable adverse events are grouped by route of administration (Upper and lower gastrointestinal routes; Not mention of the routes; Capsule).
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  First Author, Year (Ref.)                                                                                                                            AEs                                                                                                                       The number of patients with AEs   Sample size   Causality between AEs and FMT   Routes of infusion
  ---------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- --------------------------------- ------------- ------------------------------- -------------------------------------------------------------------------
  **Upper and lower gastrointestinal routes**                                                                                                                                                                                                                                                                                                                    
  **Angelberger, 2013 \[[@pone.0161174.ref052]\]**                                                                                                     Sore throat                                                                                                               5                                 5             Definitely                      Nasojejunal tube and enema
  Fever; Temporary increase in CRP; Worsening of diarrhea; Flatulence; Vomiting                                                                        Probably                                                                                                                                                                                                  
  **Vandelplas, 2014 \[[@pone.0161174.ref038]\]**                                                                                                      Vomiting; Profuse sweating; Paleness; Tachycardia; Fever                                                                  1                                 1             Probably                        Colonoscopy and nasoduodenal tube
  **Russell, 2014 \[[@pone.0161174.ref082]\]**                                                                                                         Mucoid stools; Bloating; Cramping; Loose stools; Abdominal pain; Gassiness; Diarrhea; Blood in stool                      3                                 10            Probably                        Colonoscopy and nasogastric tube
  **Greenberg, 2013 \[[@pone.0161174.ref083]\]**                                                                                                       Transient worsening of abdominal distension                                                                               3                                 16            Probably                        Colonoscopy and nasojejunal infusion
  **Not mention of the routes**                                                                                                                                                                                                                                                                                                                                  
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**                                                                                                           Death from aspiration; Minor mucosal tear                                                                                 12                                80            Definitely                      NR
  Fever; Bloating and abdominal discomfort; Abdominal pain                                                                                             Probably                                                                                                                                                                                                  
  IBD flare; Self-limited diarrheal illness; Hip pain; Pertussis; Nausea; Death from pneumonia; Diarrhea, encephalopathy and pancytopenia; Colectomy                                                                                                                                                               Possibly                                      
  **Brandt, 2013 \[[@pone.0161174.ref085]\]**                                                                                                          Transient abdominal distension with bloating                                                                              2                                 12            Probably                        NR
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**                                                                                                          Diarrhea or nullloose stoolnull; Bloating; Flatus; Constipation; Abdominal pain; GERD (gastroesophageal reflux disease)   12                                45            Probably                        NR
  **Obi, 2014 \[[@pone.0161174.ref087]\]**                                                                                                             Bowel perforation                                                                                                         1                                 20            Definitely                      NR
  **Borody, 2003 \[[@pone.0161174.ref067]\]**                                                                                                          Flatulence; Rectal discomfort; Nausea; Abdominal cramping; Bloating; Headache; Abdominal pain                             7                                 24            Probably                        Combination of colonoscopy and/ or rectal enema and/or nasojejunal tube
  **Capsule**                                                                                                                                                                                                                                                                                                                                                    
  **Youngster, 2014 \[[@pone.0161174.ref059]\]**                                                                                                       Abdominal cramping and bloating                                                                                           6                                 20            Possibly                        Capsule

10.1371/journal.pone.0161174.t004

###### Adverse events are grouped by their causality with fecal microbiota transplantation.
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  First Author, Year (Ref.)                              Definitely related to FMT                   Probably related to FMT                                                                                                                Possibly related to FMT                                                                                                                              Unrelated to FMT
  ------------------------------------------------------ ------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------
  **Vermeire, 2012 \[[@pone.0161174.ref060]\]**                                                      Fever; Abdominal tenderness; Transient increase of CRP                                                                                                                                                                                                                                      
  **Kump, 2013 \[[@pone.0161174.ref068]\]**                                                          Fever; Temporary increase of CRP and IL-6; Increase in stool frequency                                                                                                                                                                                                                      
  **Angelberger, 2013 \[[@pone.0161174.ref052]\]**       Sore throat                                 Fever; Temporary increase in CRP; Worsening of diarrhea; Flatulence; Vomiting                                                          Itchiness; Erythema; Paresthesia of the hip; Blisters on the tongue                                                                                  Common cold; Unexplained pancreatitis; Collapse due to orthostatic disorder
  **Zhang, 2013 \[[@pone.0161174.ref069]\]**                                                                                                                                                                                                Severe cold                                                                                                                                          
  **Cui, 2014 \[[@pone.0161174.ref041]\]**                                                           Fever; Increased diarrhea                                                                                                                                                                                                                                                                   
  **Quera, 2013 \[[@pone.0161174.ref044]\]**                                                         Fever; Bacteremia                                                                                                                                                                                                                                                                           
  **Kunde, 2013 \[[@pone.0161174.ref070]\]**                                                         Fever; Chills; Abdominal fullness; Lower back pain; Nausea; Vomiting                                                                   Headache, UC flare                                                                                                                                   Cervical lymphadenopathy
  **Vandelplas, 2014 \[[@pone.0161174.ref038]\]**                                                    Vomiting; Profuse sweating; Paleness; Tachycardia; Fever                                                                                                                                                                                                                                    
  **Russell, 2014 \[[@pone.0161174.ref082]\]**                                                       Mucoid stools; Bloating; Cramping, Loose stools; Abdominal pain; Gassiness; Diarrhea; Blood in stool                                                                                                                                                                                        
  **Van Nood, 2013 \[[@pone.0161174.ref061]\]**                                                      Belching; Nausea; Abdominal cramps; Diarrhea; Abdominal pain; Infection; Dizziness combined with diarrhea; Constipation                                                                                                                                                                     Symptomatic choledocholithiasis
  **Gustafsson, 1998 \[[@pone.0161174.ref071]\]**                                                    Diarrhea                                                                                                                                                                                                                                                                                    
  **Lee CH, 2014 \[[@pone.0161174.ref072]\]**                                                        Transient constipation; Excess flatulence                                                                                                                                                                                                                                                   
  **Hamilton, 2012 \[[@pone.0161174.ref073]\]**                                                      Irregularity of bowel movements; Excessive flatulence                                                                                                                                                                                                                                       
  **Khoruts, 2010 \[[@pone.0161174.ref074]\]**                                                       Constipation; Irregularity of bowel movements                                                                                                                                                                                                                                               
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**             Death from aspiration; Minor mucosal tear   Fever; Bloating; Abdominal discomfort;Abdominal pain post FMT colonoscopy                                                              IBD flare; Self-limited diarrheal illness; Hip pain; Pertussis; Nausea; Death from pneumonia; Diarrhea; Encephalopathy and pancytopenia; Colectomy   Cerebrovascular accident, nausea and vomiting; Fall and sustained hip fracture; Influenza and diarrhea (non-CDI); Catheter infection
  **Pierog, 2014 \[[@pone.0161174.ref075]\]**                                                                                                                                                                                               Appendicitis                                                                                                                                         
  **Youngster, 2014 \[[@pone.0161174.ref059]\]**                                                     Infectious irritable bowel symptoms                                                                                                                                                                                                                                                         Relapse of severe CDI
  **Silverman, 2010 \[[@pone.0161174.ref076]\]**                                                                                                                                                                                            Urinary tract infections;                                                                                                                            
  **Hohmann, 2014 \[[@pone.0161174.ref039]\]**                                                       Irregularity of bowel movements; Weakness; Fatigue; Decreased appetite; Abdominal pain; Night sweats; Fever; Cytomegalovirus colitis   Minor joint pains; Weight loss                                                                                                                       
  **De Leon, 2013 \[[@pone.0161174.ref040]\]**                                                       Transient relapse of UC                                                                                                                                                                                                                                                                     
  **Schwartz, 2013 \[[@pone.0161174.ref043]\]**                                                      Norovirus Gastroenteritis                                                                                                                                                                                                                                                                   
  **Brandt, 2012 \[[@pone.0161174.ref020]\]**                                                                                                                                                                                               Peripheral neuropathy; Sjogren ' s disease; Idiopathic Thrombocytopenic purpura; Rheumatoid arthritis                                                Death for unknown causes, metastatic colon cancer, metastatic ovarian cancer, pneumonia, myocardial infarction, cerebral vascular accident and sepsis
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**                                                                                                                                                                                               CDI relapse                                                                                                                                          Death from pneumonia; Death from superior mesenteric vein thrombosis; Death from ovarian cancer
  **Aas, 2003 \[[@pone.0161174.ref062]\]**                                                                                                                                                                                                  Death from peritonitis                                                                                                                               Death from pneumonia
  **Mandalia, 2014 \[[@pone.0161174.ref078]\]**                                                      Diverticulitis; Fever                                                                                                                                                                                                                                                                       
  **MacConnachie, 2009 \[[@pone.0161174.ref042]\]**                                                                                                                                                                                         Upper gastrointestinal hemorrhage                                                                                                                    
  **Kronman, 2015 \[[@pone.0161174.ref063]\]**                                                       Vomiting; Mucoid stools                                                                                                                                                                                                                                                                     
  **Dutta, 2014 \[[@pone.0161174.ref079]\]**                                                         Low-grade fever; Bloating                                                                                                                                                                                                                                                                   
  **Friedman-Moraco, 2014 \[[@pone.0161174.ref088]\]**                                                                                                                                                                                                                                                                                                                                           Cerebral vascular event; Bronchiolitis obliterans
  **Ray, 2014 \[[@pone.0161174.ref080]\]**                                                           Pain/nausea; Bloating/cramps; Vomiting; Abdominal pain                                                                                 Continuing diarrhea                                                                                                                                  Cerebrovascular accident
  **Pinn, 2014 \[[@pone.0161174.ref026]\]**                                                          A transient increase in flatus                                                                                                                                                                                                                                                              
  **Mattila, 2012 \[[@pone.0161174.ref019]\]**                                                                                                                                                                                                                                                                                                                                                   Died of unrelated illnesses
  **Satokari, 2015 \[[@pone.0161174.ref053]\]**                                                      Mild transient fever                                                                                                                                                                                                                                                                        
  **Trubiano, 2013 \[[@pone.0161174.ref089]\]**                                                                                                                                                                                                                                                                                                                                                  Renal failure, episodes of VAP (ventilator-associated pneumonia) and death
  **Garborg, 2010 \[[@pone.0161174.ref090]\]**                                                                                                                                                                                                                                                                                                                                                   Died of serious co-morbid conditions
  **Borody, 2003 \[[@pone.0161174.ref067]\]**            Sore throat                                 Flatulence, rectal discomfort, nausea, abdominal cramping, bloating, headache, abdominal pain                                                                                                                                                                                               
  **Sun, 2014 \[[@pone.0161174.ref045]\]**                                                           Multi-organism bacteremia                                                                                                                                                                                                                                                                   
  **Mandalia, 2014 \[[@pone.0161174.ref081]\]**                                                      Abdominal pain                                                                                                                                                                                                                                                                              
  **Greenberg, 2013 \[[@pone.0161174.ref083]\]**                                                     Transient worsening of abdominal distension                                                                                                                                                                                                                                                 
  **Brandt, 2013 \[[@pone.0161174.ref085]\]**                                                        Transient abdominal distension with bloating                                                                                                                                                                                                                                                
  **Fischer, 2014 \[[@pone.0161174.ref091]\]**                                                                                                                                                                                                                                                                                                                                                   Multi-organ failure
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**                                                        Diarrhea; Bloating; Flatus; Constipation; Abdominal pain; GERD (gastroesophageal reflux disease)                                                                                                                                                                                            Infections; recurrent CDI; Death of lung cancer
  **Wang, 2013 \[[@pone.0161174.ref064]\]**                                                          Diarrhea                                                                                                                                                                                                                                                                                    
  **Fischer, 2014 \[[@pone.0161174.ref092]\]**                                                                                                                                                                                                                                                                                                                                                   Refractory CD, refractory CDI, UC flare, non-infectious severe diarrhea, recurrent CDI and worsening CD
  **Obi, 2014 \[[@pone.0161174.ref087]\]**               Bowel perforation                                                                                                                                                                                                                                                                                                                       Diarrhea
  **Suskind, 2015 \[[@pone.0161174.ref065]\]**           Rhinorrhea, sore throat                     Abdominal pain, bloating, diarrhea, flatulence                                                                                                                                                                                                                                              Mild stuffy nose,
  **Suskind, 2015 \[[@pone.0161174.ref066]\]**                                                       Nasal stuffiness, flatulence                                                                                                           Bloating                                                                                                                                             Vomiting, developed *C difficile* diarrhea
  **Cammarota, 2015 \[[@pone.0161174.ref049]\]**                                                     Diarrhea, bloating and abdominal cramping                                                                                                                                                                                                                                                   
  **Rossen, 2015 \[[@pone.0161174.ref050]\]**                                                        Transient borborygmia, increase of stool frequency, vomiting, transient fever,                                                                                                                                                                                                              Suspicion of a small bowel perforation, cytomegalovirus infection, abdominal pain, cervix carcinoma
  **Moayyedi, 2015 \[[@pone.0161174.ref056]\]**                                                                                                                                                                                                                                                                                                                                                  Crohn's colitis, active ulcerative colitis, *Clostridium difficile* toxin positive

### Donors and AEs {#sec023}

So far, there is no unified standard to screen the stool samples from donors. The following donor screening tests were applied to the donors in the selected 50 publications: viral screenings (hepatitis A virus, hepatitis B virus, hepatitis C virus, Epstein--Barr virus, human immunodeficiency virus, treponema pallidum, and cytomegalovirus), stool tests for *Clostridium difficile* toxin, and routine bacterial culture for enteric pathogens (*Escherichia coli*, *Salmonella*, *Shigella*, *Yersinia*, *Campylobacter*), parasites and ova. However, the donors who were in the latent period of infection could not be excluded by the above screening tests and thus these donors might contribute to the development of infectious AEs.

In addition, individual differences of donors may also lead to AEs. For example, one patient (a 1-year-old girl) developed fever, vomiting and tachycardia after receiving the fecal transplant from her brother, while she well tolerated the transplant from her niece \[[@pone.0161174.ref038]\]. For the infrequent infection of cytomegalovirus in FMT receipt, it may be caused by the donors with young age \[[@pone.0161174.ref039]\]. Finally unrecognized pathogens that were carried by donors might induce AEs \[[@pone.0161174.ref040]\].

Related donors (family members) for FMT were reported in 11 publications. Unrelated donors were reported in 9 publications.

### Preparation and route of administration and AEs {#sec024}

For FMT via upper gastrointestinal routes, the recipients were prepared in fasting condition. For FMT via lower gastrointestinal routes, bowel lavage and/or antibiotics were given to the recipients before FMT. However, no association of AEs with the preparation of FMT was found in the 50 publications. Of note, in Bota Cui's report, the recipients who took metoclopramide before FMT manifested fewer AEs, suggesting metoclopramide might potentially help avoid the AEs \[[@pone.0161174.ref041]\].

The routes of administration are listed as follows according to the frequency that they were used: colonoscopy (26 publications), retention enema (8 publications), nasogastric tube (6 publications), nasojejunal tube (5 publications), gastroscopy (2 publications), sigmoidoscopy (1 publication), nasoduodenal tube (4 publications), enteroscopy (1 publication), esophagogastroduodenoscopy (1 publication) and capsule (1 publication). Among the above routes of administration, lower gastrointestinal routes include colonoscopy, sigmoidoscopy and retention enema. Upper gastrointestinal routes include the remaining means. Compared with upper gastrointestinal routes, lower gastrointestinal routes were more widely used. After exclusion of the publications in which the routes of administration were not clearly stated, the proportion of patients affected by FMT-attributable AE is 43.6% (89/204) for upper gastrointestinal routes of FMT administration, while the incidence dropped to 17.7% (76/430) for lower gastrointestinal routes. The FMT-attributable AEs were grouped by routes of administration (Tables [2](#pone.0161174.t002){ref-type="table"} and [3](#pone.0161174.t003){ref-type="table"}).

Among the 78 kinds of AEs, 5 kinds were definitely related to endoscopic manipulation. Of these, nasal stuffiness, sore throat, rhinorrhea and upper gastrointestinal hemorrhage happened on a total of 8 patients in 4 publications, which were attributable to upper gastrointestinal routes administration. It seems that patients are likely to be injured by invasive endoscope procedures for upper gastrointestinal routes of FMT administration.

The commonest attributable AE was abdominal discomfort for both upper and lower gastrointestinal routes, including abdominal pain, increased stool frequency, flatulence, bloating, cramps and other nonspecific symptoms. For upper gastrointestinal routes of administration in 12 publications, 29.9% (61/204) patients (in 9 publications) were reported to suffer abdominal discomfort after FMT. For lower gastrointestinal routes in 22 publications, 13.0% (56/430) patients (in 10 publications) developed abdominal discomfort after FMT. The upper gastrointestinal routes were therefore more likely to develop abdominal discomfort compared with lower gastrointestinal. The second commonest attributable AE was transient fever which was happened on 3.4% (7/204) and 2.8% (12/430) patients for upper and lower gastrointestinal routes of FMT administration, respectively ([Table 2](#pone.0161174.t002){ref-type="table"}).

Classification of AEs based on severity {#sec025}
---------------------------------------

Mild to moderate AEs such as abdominal pain, abdominal cramping, flatulence, increased stool frequency, constipation, vomiting, belching, fever and transient increase of C-reactive protein (CRP) were reported in most of the selected 50 publications and ususally did not cause critical clinical outcome. Hence, we paid emphatic attention to SAEs and listed 44 kinds of SAEs that were reported in 27 publications ([Table 5](#pone.0161174.t005){ref-type="table"}), of which 18 kinds were associated with FMT procedure. Totally 9.2% (100/1089) patients developed SAEs. The incidences of SAEs were 2.0% (4/196) and 6.1% (40/659) for upper and lower gastrointestinal routes respectively, which suggest that lower gastrointestinal routes of FMT administration induce more SAEs compared with upper routes.

10.1371/journal.pone.0161174.t005

###### Serious adverse events (SAEs) of fecal microbiota transplantation.
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  First Author, Year (Ref.)                              The total number of patients                              Patient Preparation to FMT                             Infused Stools         Route of Infusion                    Donor Relation-ship     Number of Infusion   SAE                                                                                                                                                     Causality between AEs and FMT   Day post-FMT event occurred   How to relieve the AE                  Follow-Up      
  ------------------------------------------------------ --------------------------------------------------------- ------------------------------------------------------ ---------------------- ------------------------------------ ----------------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ----------------------------- -------------------------------------- -------------- --------------
  **De Leon, 2013 \[[@pone.0161174.ref040]\]**           1 UC/CDI                                                  Antibiotics                                            600ml infusion         Colonoscopy                          Related                 1                    Transient relapse of UC                                                                                                                                 Probably                        9 days                        Prednisone, mesalamine                 2 weeks        
  **Hohmann, 2014 \[[@pone.0161174.ref039]\]**           1 UC                                                      NR                                                     NR                     Home FMT                             Related                 4                    Cytomegalovirus colitis                                                                                                                                 Probably                        Several weeks                 Anti- cytomegalovirus therapy          NR             
  **Van Nood, 2013 \[[@pone.0161174.ref061]\]**          16CDI                                                     Bowel lavage                                           500ml infusion         Nasoduodenal tube                    Unrelated               1 or 2               Symptomatic choledocholithiasis                                                                                                                         Unrelated                       During follow-up              Stone extraction                       15 weeks       
  **Schwartz, 2013 \[[@pone.0161174.ref043]\]**          13 CDI                                                    Antibiotics, Bowel preparation                         NR                     Colonoscopy                          Related                 NR                   Norovirus Gastroenteritis;                                                                                                                              Probably                        2 days                        Self-limited                           NR             
  Norovirus Gastroenteritis; Relapse of CDI              Unrelated                                                 12 days                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **Brandt, 2012 \[[@pone.0161174.ref020]\]**            77 CDI                                                    Antibiotics, Bowel preparation                         300--700ml infusion    Colonoscopy                          Related/Unrelated       1 or 2               Peripheral neuropathy                                                                                                                                   Possibly                        NR                            NR                                     3--68 months   
  Sjogren ' s disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Idiopathic thrombocytopenic purpura                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Rheumatoid arthritis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Died of unrelated diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**            13 CDI                                                    NR                                                     300--600 ml infusion   Colonoscopy                          NR                      1                    Death                                                                                                                                                   B strep pneumonia               Unrelated                     1 month                                Died           1--10 months
  Superior mesenteric vein thrombosis                    Unrelated                                                 5 months                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Ovarian cancer                                         Unrelated                                                 7 months                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Relapse of CDI                                         Unrelated                                                 7 months                                               Relapse of CDI                                                                                                                                                                                                                                                                                                                                                                       
  **Youngster, 2014 \[[@pone.0161174.ref059]\]**         20 CDI                                                    NR                                                     650μl\*15              Capsule                              Unrelated               1 or 2               Relapse of severe CDI                                                                                                                                   Unrelated                       NR                            Receiving the remaining 15 capsules    8 weeks        
  **Aas, 2003 \[[@pone.0161174.ref062]\]**               18 recurrent *Clostridium difficile* Colitis              NR                                                     ≤30 g                  Nasogastric tube                     NR                      1                    Death                                                                                                                                                   Peritonitis                     Possibly                      3 days                                 Died           90 days
  Pneumonia                                              Unrelated                                                 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **Kunde, 2013 \[[@pone.0161174.ref070]\]**             10 UC                                                     NR                                                     70--113 g              Enema                                Related and unrelated   5                    UC flare                                                                                                                                                Possibly                        Third week                    Corticosteroid enema                   1 month        
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**             80 CDI in Immunoco-mpromised Patients                     NR                                                     NR                     Colonoscopy or others                NR                      1 or more            Death                                                                                                                                                   Pneumonia                       Possibly                      13 days                                Died           3--46 months
  Aspiration                                             Definitely                                                1 day                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Hospitalizations                                       Fever, diarrhea, encephalopathy and pancytopenia          Possibly                                               4 days                 NR                                                                                                                                                                                                                                                                                                                                                            
  Abdominal pain post FMT colonoscopy                    Probably                                                  0 day                                                  Self-limited                                                                                                                                                                                                                                                                                                                                                                         
  IBD flare                                              Possibly                                                  \< 84 days                                             NR                                                                                                                                                                                                                                                                                                                                                                                   
  Cerebrovascular accident; nausea and vomiting          Unrelated                                                 21 days                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Colectomy                                              Possibly                                                  \< 28 days                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Fall and sustained hip fracture                        Unrelated                                                 84 days                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Influenza B and diarrhea (non-CDI)                     Unrelated                                                 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Catheter infection                                     Unrelated                                                 14 days                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **Mandalia, 2014 \[[@pone.0161174.ref078]\]**          1 CDI/CD                                                  NR                                                     100g                   Colonoscopy                          NR                      1                    Diverticulitis, fever                                                                                                                                   Probably                        2--3 hours                    Antibiotics                            3 months       
  **Quera, 2013 \[[@pone.0161174.ref044]\]**             1 CD/CDI                                                  NR                                                     NR                     Colonoscopy                          NR                      1                    Bacteriemia                                                                                                                                             Probably                        24 hours                      Aztreonam                              5 months       
  **Pierog, 2014 \[[@pone.0161174.ref075]\]**            6 CDI                                                     Bowel lavage                                           250--500 mL infusion   Colonoscopy                          Related                 1                    Appendicitis                                                                                                                                            Possibly                        2 weeks                       Appendectomy                           12 weeks       
  **Silverman, 2010 \[[@pone.0161174.ref076]\]**         7 CDI                                                     Stop anti-CDI antimicrobial                            50 mL infusion         Enema                                Related                 1 or 2               Post infectious irritable bowel symptoms                                                                                                                Unrelated                       NR                            Cotrimoxazole                          14 months      
  Urinary tract infections                               Ampicillin/ gentamicin and ciprofloxacin                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  **Friedman-Moraco, 2014 \[[@pone.0161174.ref088]\]**   2 CDI                                                     NR                                                     80mL                   Nasojejunal tube                     Related                 2                    Cerebral vascular event                                                                                                                                 Unrelated                       NR                            NR                                     1 year         
  250mL                                                  Colonoscopy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  325mL                                                  Colonoscopy                                               Unrelated                                              2                      Bronchiolitis obliterans and death   5 days                  NR                                                                                                                                                                                                                                                                                               
  100mL                                                  Nasojejunal tube                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  **Ray, 2014 \[[@pone.0161174.ref080]\]**               20 CDI                                                    Stop all antibiotics                                   NR                     Colonoscopy                          Related and unrelated   1                    Cerebrovascular accident                                                                                                                                Unrelated                       \> 1 month                    NR                                     3 months       
  **Mattila, 2012 \[[@pone.0161174.ref019]\]**           70 CDI                                                    Antibiotics were stopped Colonic lavage                100mL suspension       Colonoscopy                          Related and unrelated   1 or more            Died of unrelated illnesses                                                                                                                             Unrelated                       Within 1 year                 NR                                     1 year         
  No response and death                                  Unrelated                                                 Within 3 months                                                                                                                                                                                                                                                                                                                                                                                                                             
  **Trubiano, 2013 \[[@pone.0161174.ref089]\]**          1 CDI                                                     NR                                                     30mL suspension        Nasogastric tube                     Related                 1                    Renal failure, episodes of ventilator-associated pneumonia and death                                                                                    Unrelated                       NR                            Continuous renal replacement therapy   NR             
  **Garborg, 2010 \[[@pone.0161174.ref090]\]**           40 recurrent *Clostridiumdifficil*e-associated diarrhea   Fast                                                   50--100 g              Gastroscopy or colonoscopy           Related and unrelated   1 or 2               Wegener ' s granulomatosis, acute myelogenous leukaemia, advanced cardiovascular disease developed fulminant colitis and underwent subtotal colectomy   Unrelated                       3 weeks-- 2 months            Died                                   2 months       
  **Sun, 2014 \[[@pone.0161174.ref045]\]**               1 CDI                                                     NR                                                     NR                     Colonoscopy                          NR                      NR                   Multi-organism bacteremia                                                                                                                               Probably                        NR                            Ampicillin/sulbactam; vancomycin       NR             
  **Fischer, 2014 \[[@pone.0161174.ref091]\]**           17 CDI                                                    Bowel preparation                                      NR                     Colonoscopy                          Related and unrelated   1, 2 or 3            Multi-organ failure and death                                                                                                                           Immunosuppression               Unrelated                     NR                                     NR             NR
  Septic shock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**            45 CDI                                                    NR                                                     NR                     NR                                   NR                      NR                   Infections; Recurrent CDI; Death of lung cancer                                                                                                         Unrelated                       NR                            NR                                     6 months       
  **Fischer, 2014 \[[@pone.0161174.ref092]\]**           41 CDI/IBD (21 CD, 19UC, 1 indeterminate colitis)         NR                                                     NR                     Colonoscopy or Sigmoidoscopy         NR                      1 or 2               Refractory CD, refractory CDI, UC flare, non-infectious severe diarrhea, recurrent CDI and worsening CD                                                 Unrelated                       NR                            NR                                     NR             
  **Obi, 2014 \[[@pone.0161174.ref087]\]**               20 CDI                                                    NR                                                     NR                     NR                                   NR                      NR                   Bowel perforation                                                                                                                                       Definitely                      NR                            Colectomy                              4 months       
  **Suskind, 2015 \[[@pone.0161174.ref066]\]**           4 UC                                                      Omeprazole, rifaximin, MiraLAX and bowel preparation   Infusion of 30 mL      Nasogastric tube                     NR                      1                    Developed *C difficile* diarrhea                                                                                                                        Unrelated                       3 months                      Vancomycin                             6 months       
  4 months                                               NR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  **Rossen, 2015 \[[@pone.0161174.ref050]\]**            50 UC                                                     Bowel lavage                                           120 g                  Nasoduodenal tube                    Unrelated               2                    Suspicion of a small bowel perforation                                                                                                                  Unrelated                       5 weeks                       Antibiotics                            12 weeks       
  Cytomegalovirus infection                              7 weeks                                                   Ganciclovir                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Abdominal pain                                         11 weeks                                                  Spontaneous recovery                                                                                                                                                                                                                                                                                                                                                                                                                        
  Cervix carcinoma                                       6 weeks                                                   Operation                                                                                                                                                                                                                                                                                                                                                                                                                                   
  **Moayyedi, 2015 \[[@pone.0161174.ref056]\]**          75 UC                                                     NR                                                     50 mL                  Retention enema.                     Unrelated               6                    Three patients had their diagnoses changed to Crohn's colitis from ulcerative colitis.                                                                  Unrelated                       NR                            NR                                     12 months      
  Active ulcerative colitis                              Three weeks                                               Urgent colectomy                                                                                                                                                                                                                                                                                                                                                                                                                            
  *Clostridium difficile* toxin positive                 After study exit                                          NR                                                                                                                                                                                                                                                                                                                                                                                                                                          

The FMT-attributable (definitely, probably and possibly related) SAEs included death, pathogen infections, IBD flare, auto-immune diseases, and FMT procedure related injury, etc, while the FMT unrelated SAEs covered death or hospitalization caused by underlying conditions. The commonest SAEs were death, severe infections and relapse of CDI and IBD.

As the most devastating SAEs, death happened on 38 patients in 10 publications ([Table 6](#pone.0161174.t006){ref-type="table"}) and the mortality rate was 3.5% (38/1089). Of these deaths, 1 was definitely related, 2 were possibly related, and 35 were unrelated to FMT. The death that was definitely related to FMT was caused by aspiration during sedation of colonoscopy \[[@pone.0161174.ref042]\]. The other two deaths were associated with infections which might be outcomes of either FMT procedures or underlying immunocompromised status. Except for the above 3 patients, no evidence supported the notion that the remaining deaths could have been caused or facilitated by preparation, route of infusion, donor, number of infusion or the FMT procedure.

10.1371/journal.pone.0161174.t006

###### Summary of death after fecal microbiota transplantation.
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  First Author, Year (Ref.)                              The total number of patients                            Patient Preparation to FMT                 Infused Stools         Route of Infusion            Donor Relationship      Number of Infusion   Cause of death                                                                                                                                          Causality between AEs and FMT   Day post-FMT event occurred   Follow-Up
  ------------------------------------------------------ ------------------------------------------------------- ------------------------------------------ ---------------------- ---------------------------- ----------------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ----------------------------- --------------
  **Garborg, 2010 \[[@pone.0161174.ref090]\]**           40 recurrent Clostridiumdifficile-associated diarrhea   Fast                                       50--100 g              Gastroscopy or colonoscopy   Related and unrelated   1 or 2               Wegener ' s granulomatosis, acute myelogenous leukaemia, advanced cardiovascular disease developed fulminant colitis and underwent subtotal colectomy   Unrelated                       3 weeks-- 2 months            2 months
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**            13 CDI                                                  NR                                         300--600 ml infusion   Colonoscopy                  NR                      1                    B strep pneumonia                                                                                                                                       Unrelated                       1 month                       1--10 months
  Superior mesenteric vein thrombosis                    Unrelated                                               5 months                                                                                                                                                                                                                                                                                                                                                          
  Ovarian cancer                                         Unrelated                                               7 months                                                                                                                                                                                                                                                                                                                                                          
  **Aas, 2003 \[[@pone.0161174.ref062]\]**               18 recurrent *Clostridium difficile* Colitis            NR                                         ≤30 g                  Nasogastric tube             N46R                    1                    Peritonitis                                                                                                                                             Possibly                        3 days                        90 days
  Pneumonia                                              Unrelated                                               14 days                                                                                                                                                                                                                                                                                                                                                           
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**             80 CDI in Immunocom-promised Patients                   NR                                         NR                     Colonoscopy or others        NR                      1 or more            Pneumonia                                                                                                                                               Possibly                        13 days                       3--46 months
  Aspiration                                             Definitely                                              1 day                                                                                                                                                                                                                                                                                                                                                             
  **Friedman-Moraco, 2014 \[[@pone.0161174.ref088]\]**   2 CDI                                                   NR                                         325mL                  Colonoscopy                  Unrelated               2                    Bronchiolitis obliterans                                                                                                                                Unrelated                       5 days                        NR
  100mL                                                  Nasojejunal tube                                                                                                                                                                                                                                                                                                                                                                                                          
  **Mattila, 2012 \[[@pone.0161174.ref019]\]**           70 CDI                                                  Antibiotics were stopped, colonic lavage   100mL suspension       Colonoscopy                  Related and unrelated   1 or more            Unrelated illnesses                                                                                                                                     Unrelated                       Within 1 year                 1 year
  No response and died                                   Unrelated                                               Within 3 months                                                                                                                                                                                                                                                                                                                                                   
  **Brandt, 2012 \[[@pone.0161174.ref020]\]**            77 CDI                                                  Antibiotics, bowel preparation             300--700ml infusion    Colonoscopy                  Related/Unrelated       1 or 2               Death for unknown causes, metastatic colon cancer, metastatic ovarian cancer, pneumonia, myocardial infarction, cerebral vascular accident and sepsis   Unrelated                       NR                            3--68 months
  **Trubiano, 2013 \[[@pone.0161174.ref089]\]**          1 CDI                                                   NR                                         30 mL                  Nasojejunal tube             Related                 1                    Renal failure, episodes of ventilator-associated pneumonia                                                                                              Unrelated                       NR                            NR
  **Fischer, 2014 \[[@pone.0161174.ref092]\]**           17 CDI                                                  Bowel preparation                          NR                     Colonoscopy                  Related and unrelated   1 or 2 or 3          Immunosuppression                                                                                                                                       Unrelated                       NR                            NR
  Septic shock                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**            45 CDI                                                  NR                                         NR                     NR                           NR                      NR                   Lung cancer                                                                                                                                             Unrelated                       NR                            6 months

Twenty-seven patients were reported to be hospitalized or die for infection in 12 publications (CDI was not included) ([Table 7](#pone.0161174.t007){ref-type="table"}). The incidence of severe infection was 2.5% (27/1089). Among the 27 cases of severe infection, 8 cases were probably or possibly related to FMT and the remaining 19 cases were unrelated to FMT.Out of the 8 cases of severe infection, 2 were viral infection, 2 were bacteriemia infection, and the remaining 4 were infection of unknown pathogens. The pathogens that caused the 2 cases of viral infection were cytomegalovirus \[[@pone.0161174.ref039]\] and norovirus \[[@pone.0161174.ref043]\] respectively and the pathogens that caused the 2 cases of bacteriemia infection were *Escherichia coli*, *Proteus mirabilis*, *Citrobacter koseri*, and *Enterococcus faecium* \[[@pone.0161174.ref044], [@pone.0161174.ref045]\]. The cytomegalovirus infection happened after home FMT and was suspected to be probably related to a child donor without strict donor screening. The noroviurs infection was speculated to be probably related to environmental contamination by an endoscopy suite employee. IBD flare happened on 7 patients (4 UC and 3 CD) post-FMT in the 50 selected publications ([Table 8](#pone.0161174.t008){ref-type="table"}) and its incidence reached 0.6% (7/1089). Most patients who suffered from IBD flare were those with low immunity, such as kids, aged people and immunocompromised ones. Of note, patients with IBD flare were administered FMT via lower gastrointestinal routes, such as colonoscopy, sigmoidoscopy or enema. Therefore, IBD flare should arouse attention when FMT was administered via lower gastrointestinal routes. So far, the association between donors and IBD flare has not been defined, for some unrecognized pathogens from donors' stool might also lead to IBD flare.

10.1371/journal.pone.0161174.t007

###### Summary of infections after fecal microbiota transplantation.

![](pone.0161174.t007){#pone.0161174.t007g}

  First Author, Year (Ref.)                        The total number of patients                   Patient Preparation to FMT       Infused Stools         Route of Infusion       Donor Relationship   Number of Infusion   SAE (infections)                                                                                                              Causality between AEs and FMT   Day post-FMT event occurred   How to relieve the AE              Follow-Up
  ------------------------------------------------ ---------------------------------------------- -------------------------------- ---------------------- ----------------------- -------------------- -------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------- ----------------------------- ---------------------------------- --------------
  **Hohmann, 2014 \[[@pone.0161174.ref039]\]**     1 UC                                           NR                               NR                     Home FMT                Related              4                    Cytomegalovirus colitis                                                                                                       Probably                        Several weeks                 Anti- cytomegalovirus therapy      NR
  **Schwartz, 2013 \[[@pone.0161174.ref043]\]**    13 CDI                                         Antibiotics, Bowel preparation   NR                     Colonoscopy             Related              NR                   Norovirus Gastroenteritis                                                                                                     Probably                        2 days                        Self-limited                       NR
  Norovirus Gastroenteritis                        Unrelated                                      12 days                                                                                                                                                                                                                                                                                                                                                  
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**      13 CDI                                         NR                               300--600 ml infusion   Colonoscopy             NR                   1                    B strep pneumonia                                                                                                             Unrelated                       1 month                       Died                               1--10 months
  **Aas, 2003 \[[@pone.0161174.ref062]\]**         18 recurrent *Clostridium difficile* Colitis   NR                               ≤30 g                  Nasogastric tube        NR                   1                    Peritonitis                                                                                                                   Possibly                        3 days                        Died                               90 days
  Pneumonia                                        Unrelated                                      14 days                                                                                                                                                                                                                                                                                                                                                  
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**       80 CDI in Immunocom-promised Patients          NR                               NR                     Colonoscopy or others   NR                   1 or more            Died of pneumonia                                                                                                             Possibly                        13 days                       Died                               3--46 months
  Influenza B and diarrhea (non-CDI)               Unrelated                                      3 days                           NR                                                                                                                                                                                                                                                                                                                      
  Catheter infection                               Unrelated                                      14 days                                                                                                                                                                                                                                                                                                                                                  
  **Mandalia, 2014 \[[@pone.0161174.ref078]\]**    1 CDI/CD                                       NR                               100g                   Colonoscopy             NR                   1                    Diverticulitis, fever                                                                                                         Probably                        2--3 hours                    Antibiotics                        3 months
  **Quera, 2013 \[[@pone.0161174.ref044]\]**       1 CD/CDI                                       NR                               NR                     Colonoscopy             NR                   1                    Bacteriemia                                                                                                                   Probably                        24 hours                      Aztreonam                          5 months
  **Pierog, 2014 \[[@pone.0161174.ref075]\]**      6 CDI                                          Bowel lavage                     250--500 mL infusion   Colonoscopy             Related              1                    Appendicitis                                                                                                                  Possibly                        2 weeks                       Appendectomy                       12 weeks
  **Silverman, 2010 \[[@pone.0161174.ref076]\]**   7 CDI                                          Stop anti-CDI antimicrobial      50 mL infusion         Enema                   Related              1 or 2               Post infectious irritable bowel symptoms                                                                                      Unrelated                       NR                            Cotrimoxazole                      14 months
  Urinary tract infections                         Ampicillin/ gentamicin and ciprofloxacin                                                                                                                                                                                                                                                                                                                                                                
  **Sun, 2014 \[[@pone.0161174.ref045]\]**         1 CDI                                          NR                               NR                     Colonoscopy             NR                   NR                   Multi-organism bacteremia                                                                                                     Probably                        NR                            Ampicillin/sulbactam; vancomycin   NR
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**      45 CDI                                         NR                               NR                     NR                      NR                   NR                   HCV seroconversion, urinary tract infection, viral upper respiratory infection, foot infection, eye infection, and shingles   Unrelated                       NR                            NR                                 6 months
  **Rossen, 2015 \[[@pone.0161174.ref050]\]**      50 UC                                          Bowel lavage                     120 g                  Nasoduodenal tube       Unrelated            2                    Cytomegalovirus infection                                                                                                     Unrelated                       7 weeks                       Ganciclovir                        12 weeks

10.1371/journal.pone.0161174.t008

###### Summary of relapse of inflammatory bowel disease or *Clostridium difficile* infection after fecal microbiota transplantation.
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  SAE                                              First Author, Year (Ref.)                       The total number of patients                           Patient Preparation to FMT       Infused Stools          Route of Infusion              Donor Relationship   Number of Infusion   Causality between SAEs and FMT   Day post-FMT event occurred           How to relieve the AE    Follow-Up
  ------------------------------------------------ ----------------------------------------------- ------------------------------------------------------ -------------------------------- ----------------------- ------------------------------ -------------------- -------------------- -------------------------------- ------------------------------------- ------------------------ -----------
  **Relapse of CDI**                               **Schwartz, 2013 \[[@pone.0161174.ref043]\]**   13 CDI                                                 Antibiotics, Bowel preparation   NR                      Colonoscopy                    Related              NR                   Unrelated                        12 days                               NR                       NR
  **Mellow, 2011 \[[@pone.0161174.ref077]\]**      13 CDI                                          NR                                                     300--600 ml infusion             Colonoscopy             NR                             1                    Unrelated            7 months                         NR                                    1--10 months             
  **Youngster, 2014 \[[@pone.0161174.ref059]\]**   20 CDI                                          NR                                                     650μl\*15                        Capsule                 Unrelated                      1 or 2               Unrelated            NR                               Receiving the remaining 15 capsules   8 weeks                  
  **Wilson, 2014 \[[@pone.0161174.ref086]\]**      45 CDI                                          NR                                                     NR                               NR                      NR                             NR                   Unrelated            NR                               NR                                    6 months                 
  **Suskind, 2015 \[[@pone.0161174.ref066]\]**     4 UC                                            Omeprazole, rifaximin, MiraLAX and bowel preparation   Infusion of 30 mL                Nasogastric tube        NR                             1                    Unrelated            3 months                         Vancomycin                            6 months                 
  4 months                                         NR                                                                                                                                                                                                                                                                                                                                       
  **Relapse of IBD**                               **De Leon, 2013 \[[@pone.0161174.ref040]\]**    1 UC/CDI                                               Antibiotics                      600ml infusion          Colonoscopy                    Related              1                    Probably                         9 days                                Prednisone, mesalamine   2 weeks
  **Kunde, 2013 \[[@pone.0161174.ref070]\]**       10 UC                                           NR                                                     70--113 g                        Enema                   Related and unrelated          5                    Possibly             Third week                       Corticosteroid enema                  1 month                  
  **Kelly, 2014 \[[@pone.0161174.ref084]\]**       80 CDI in Immunocomprom-ised Patients           NR                                                     NR                               Colonoscopy or others   NR                             1 or more            Possibly             \< 84 days                       NR                                    3--46 months             
  **Relapse of UC, relapse of CDI**                **Fischer, 2014 \[[@pone.0161174.ref092]\]**    41 CDI/IBD (21 CD, 19UC, 1 indeterminate colitis)      NR                               NR                      Colonoscopy or Sigmoidoscopy   NR                   1 or 2               Unrelated                        NR                                    NR                       NR

Although unrelated to FMT, CDI relapse was still another unignorable SAE, the incidence of which reached 0.9% (10/1089) in the selected 50 publications ([Table 7](#pone.0161174.t007){ref-type="table"}).

Discussion {#sec026}
==========

The human gastrointestinal tract harbors the largest number of microbes in the human body, which is referred to as the gut microbiota. Perturbations in the gut microbiota have been associated with conditions as diverse as gastrointestinal diseases and even systemic disorders \[[@pone.0161174.ref046]\]. As a microbiota-targeted therapy, FMT shows promise in controlling bacteria-associated disorders, especially recurrent or refractory CDI. Nevertheless, with the growing application of FMT, safety evaluation for FMT is increasingly urgent and potential risks of FMT must be paid attention to. Previous studies focus on the effectiveness of FMT treatment on CDI \[[@pone.0161174.ref047]\], IBD \[[@pone.0161174.ref025]\] and other digestive and nondigestive disorders \[[@pone.0161174.ref023], [@pone.0161174.ref048]\], lacking of emphasizing AEs of FMT. Landy et al \[[@pone.0161174.ref048]\] reviewed publications about FMT therapy for gastrointestinal diseases that were published before 2011 and did not find any reports regarding FMT related AEs. A more recent systematic review about FMT for IBD treatment (2012) summarized AEs that were reported in just three citations \[[@pone.0161174.ref025]\]. Lately, two randomized controlled trials of FMT for CDI \[[@pone.0161174.ref049]\] and UC \[[@pone.0161174.ref050]\] reported a high incidence of AEs, suggesting that under-reporting AEs of FMT may exist in many other cases. Therefore, there is an urgent need to systematically review and analyze the characteristics of AEs of FMT to evaluate the safety of the procedure.

Here, we selected 50 publications in which AEs of FMT were reported. Totally 78 kinds of AEs happened on 310 patients following FMT treatment. The AEs of FMT were divided into two major categories, namely related and unrelated to FMT. Our analytical results showed that the AEs related to FMT (including definitely, probably and possibly related) accounted for a larger proportion than the AEs unrelated to FMT. Moreover, we found that SAEs related to FMT such as death, viral and bacterial infections, transient relapse of IBD, were not rare and therefore deserved attention and consideration in the procedure of FMT.

Human Microbiome Project (HMP) has sampled the microbiome of many people to get a better idea of variability, and how microbes work together in complex communities. HMP implied that because the microbiome is more varied than the genome, and easier to modify, it gives a more logical starting point for individual treatments \[[@pone.0161174.ref051]\]. As observed by Angelberger et al, most AEs may be caused by the applied bacteria into the gut \[[@pone.0161174.ref052]\], which, in our opinion, could be further supported by the notion that most patients receiving FMT were under the conditions of impaired intestinal mucosal barrier and severe inflammation. In a recent observational cohort study of FMT for treating recurrent CDI, mild transient fever happened on two patients receiving FMT \[[@pone.0161174.ref053]\]. The authors speculated that FMT itself rather than glycerol used in the frozen preparations caused the AE, which was in agreement with Angelberger's opinion. Though all donors underwent blood and stool tests before FMT as recommended by FDA, some unrecognized infective agents might cause AEs of FMT. Since variability in donor microbiotas exists, it is necessary to establish a better donor screening methodologies. Moreover, the inclusion criteria of FMT donors for recurrent or refractory CDI have been established, but an agreement of the inclusion criteria of donors for IBD, IBS, metabolic diseases, and other extra-CDI have not been reached, which might engender potential risks for AEs of FMT \[[@pone.0161174.ref054], [@pone.0161174.ref055]\]. A recent placebo-controlled randomized trial demonstrated that FMT with the donation of two donors were more effective but with milder AEs than the other donors. Sequencing analysis of the microbiota was conducted for the two donors and they turned out to have similar taxonomic profiles \[[@pone.0161174.ref056]\]. Previous study also demonstrated that genetic variation in immune genes could result in variability in susceptibility to enteric infection in germfree mice \[[@pone.0161174.ref057]\]. Thus, genetic variation may paly a key role in variability in microbiota composition, susceptibility to enteric infection, response to FMT treatments, and even AEs. The emerging metagenomics, genetic and microbiota screening methodologies could be useful for identifying better donor sources for FMT therapies in the future \[[@pone.0161174.ref058]\].

Route of fecal infusion is another concern in FMT that may lead to AEs. Lower gastrointestinal routes, including colonoscopy, sigmoidoscopy, and retention enema, were more widely used than upper gastrointestinal routes. We found that the patients who received FMT treatment via upper gastrointestinal routes were more likely to develop AEs than those who received FMT treatment via lower gastrointestinal routes (43.9% vs. 20.6%). To avoid injury associated AEs during endoscopic process, noninvasive and patient-acceptable routes can be chosen for FMT treatment. Actually, a recent pilot study in which frozen capsules FMT was administered orally for patients with recurrent CDI demonstrated a high incidence of diarrhea resolution (overall 90%) but few mild AEs such as abdominal cramping and bloating \[[@pone.0161174.ref059]\]. Therefore, capsules would potentially make FMT procedure safer by avoiding procedure-related complications as well as availability for long-term usage. Furthermore, the encapsulated FMT can be accessible to a wider range of patients, especially to those who cannot withstand the endoscopic procedure. Hence, large randomized controlled studies for the safety and therapeutic efficacy of encapsulated FMT are warranted.

Though this systematic review provides a handful of valuable messages for clinical application of FMT, some limitations need to be addressed. First, the incidences of AEs might be underestimated. On one hand, since AEs usually overlapped, we took the number of patients with the most frequent kind of AE from a publication for further calculating the overall incidence of AEs. On the other hand, transient or mild AEs were sometimes ignored by researchers, resulting in the missing data of AE occurrence. Secondly, some potential confounding factors such as the health conditions of the donors, the time span from FMT exposure to the onset of the AEs and the outcomes of AEs could have substantial impacts on the classification of AEs. Thirdly, there was subjective nature in the classification of AEs. In most instances, it is impossible for us to obtain the original data of the publications we selected. Therefore we categorized AEs according to the authors' subjective description or FDA general definitions of AEs for drugs or therapy \[[@pone.0161174.ref037]\].

Conclusion {#sec027}
==========

Though FMT was validated to be a beneficial therapeutic strategy, we should pay enough attention to AEs of FMT. In order to prevent or treat AEs during or after FMT, more clinical trials and fundamental research are urged to elucidate the exact mechanism of how FMT causes AEs and set up a guideline on how to handle FMT-related AEs in different situations.
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